| Product Code: ETC6274432 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The peripheral artery disease (PAD) market in Bahrain is expanding as awareness of the disease increases and the healthcare system continues to advance. PAD is a condition that results from the narrowing or blockage of the peripheral arteries, leading to reduced blood flow to the limbs. The market for PAD treatments includes surgical interventions, stent placements, and drug therapies aimed at improving blood circulation and preventing complications. With the aging population in Bahrain and the increasing incidence of lifestyle-related diseases, the demand for effective PAD management is expected to rise. Advanced technologies, including non-invasive diagnostic tools, are also enhancing the treatment landscape for PAD in the region.
Closely related to the PAD market, the peripheral artery disease market in Bahrain continues to grow as awareness of vascular health increases. This market is also being driven by investments in vascular clinics and the adoption of minimally invasive procedures. Drug-eluting stents, angioplasty, and atherectomy devices are becoming more common in interventional settings, supported by better post-procedural care and rehabilitation services.
This market faces similar constraints to peripheral arterial disease, including delayed diagnosis and limited availability of vascular specialists. Advanced therapeutic devices are expensive and not widely distributed across all healthcare centers. Patient compliance with lifestyle modifications and medications remains low. Furthermore, there is a lack of national screening programs to identify at-risk populations early, which would otherwise drive demand for early treatment.
The Peripheral Artery Disease (PAD) Market in Bahrain is poised for growth due to aging populations and increasing diabetes prevalence. Investments can be made in diagnostic devices, interventional tools like stents and balloons, patient awareness programs, and integrated vascular care services across public and private hospitals.
This market is supported by similar policies to PAD, with emphasis on angioplasty access, lifestyle modification programs, and long-term disease management. Bahrain promotes continuous medical education in vascular medicine and ensures the availability of modern diagnostic tools like Doppler ultrasound and ankle-brachial index testing.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Peripheral Artery Disease Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Peripheral Artery Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Peripheral Artery Disease Market - Industry Life Cycle |
3.4 Bahrain Peripheral Artery Disease Market - Porter's Five Forces |
3.5 Bahrain Peripheral Artery Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Bahrain Peripheral Artery Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Bahrain Peripheral Artery Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease in Bahrain due to factors such as aging population, sedentary lifestyles, and rising rates of diabetes and obesity. |
4.2.2 Technological advancements in minimally invasive procedures and devices for the treatment of peripheral artery disease, leading to improved patient outcomes. |
4.2.3 Growing healthcare infrastructure and investments in Bahrain, supporting the diagnosis and treatment of peripheral artery disease. |
4.3 Market Restraints |
4.3.1 Limited awareness about peripheral artery disease among the general population in Bahrain, resulting in underdiagnosis and delayed treatment. |
4.3.2 High costs associated with advanced treatments and procedures for peripheral artery disease, potentially limiting access for some patients. |
4.3.3 Lack of skilled healthcare professionals specialized in the management of peripheral artery disease in Bahrain, leading to challenges in delivering optimal care. |
5 Bahrain Peripheral Artery Disease Market Trends |
6 Bahrain Peripheral Artery Disease Market, By Types |
6.1 Bahrain Peripheral Artery Disease Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Peripheral Artery Disease Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Bahrain Peripheral Artery Disease Market Revenues & Volume, By Devices, 2021- 2031F |
6.1.4 Bahrain Peripheral Artery Disease Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2 Bahrain Peripheral Artery Disease Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Peripheral Artery Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.3 Bahrain Peripheral Artery Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 Bahrain Peripheral Artery Disease Market Import-Export Trade Statistics |
7.1 Bahrain Peripheral Artery Disease Market Export to Major Countries |
7.2 Bahrain Peripheral Artery Disease Market Imports from Major Countries |
8 Bahrain Peripheral Artery Disease Market Key Performance Indicators |
8.1 Average waiting time for peripheral artery disease diagnosis and treatment in Bahrain. |
8.2 Percentage of patients receiving follow-up care and monitoring post-treatment. |
8.3 Number of hospitals or healthcare facilities offering specialized services for peripheral artery disease in Bahrain. |
9 Bahrain Peripheral Artery Disease Market - Opportunity Assessment |
9.1 Bahrain Peripheral Artery Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Bahrain Peripheral Artery Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Bahrain Peripheral Artery Disease Market - Competitive Landscape |
10.1 Bahrain Peripheral Artery Disease Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Peripheral Artery Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |